Cite
HARVARD Citation
Ebel, F. et al. (2020). Letter: a 5‐year long‐term follow‐up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis. Alimentary pharmacology & therapeutics. 51 (1), pp. 194-195. [Online].